T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.95% |
| 2 | Consumer Discretionary | 13.63% |
| 3 | Financials | 12.8% |
| 4 | Industrials | 12.27% |
| 5 | Technology | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NHC.PRA
1201
DELISTED
NATIONAL HEALTHCARE CORP PFD CONV SER A (DE)
NHC.PRA
| $14.8M | ﹤0.01% |
992,417
-990
| -0.1% | -$14.7K |
|
1202
Manhattan Associates
MANH
$11.7B
| $14.8M | ﹤0.01% |
430,129
+56,378
| +15% | +$1.86M |
|
|
VAL
1203
DELISTED
Valspar
VAL
| $14.8M | ﹤0.01% |
194,278
-128,307
| -40% | -$9.5M |
|
|
ISS
1204
DELISTED
ISOFTSTONE HLDGS LTD ADS EACH REPSTG 10 ORD SHS (CYM)
ISS
| $14.8M | ﹤0.01% |
2,710,172
+200
| +0% | +$1.08K |
|
1205
H&R Block
HRB
$6.76B
| $14.8M | ﹤0.01% |
441,308
-9,650
| -2% | -$287K |
|
1206
Waters Corp
WAT
$40.6B
| $14.7M | ﹤0.01% |
141,066
-27,990
| -17% | -$2.94M |
|
|
TEN
1207
DELISTED
Tenneco Inc. Class A Voting Common Stock
TEN
| $14.7M | ﹤0.01% |
224,250
+17,500
| +8% | +$1.08M |
|
1208
Helen of Troy
HELE
$696M
| $14.7M | ﹤0.01% |
242,900
+27,000
| +13% | +$1.68M |
|
1209
Euronet Worldwide
EEFT
$2.78B
| $14.7M | ﹤0.01% |
304,850
+42,500
| +16% | +$1.93M |
|
1210
Aspen Aerogels
ASPN
$510M
| $14.6M | ﹤0.01% |
+1,323,790
| New | +$14.4M |
|
1211
Newell Brands
NWL
$2.63B
| $14.6M | ﹤0.01% |
471,277
-3,700
| -0.8% | -$111K |
|
1212
Labcorp
LH
$26.2B
| $14.6M | ﹤0.01% |
165,719
-2,623,306
| -94% | -$227M |
|
|
INVX
1213
Innovex International
INVX
$2.15B
| $14.5M | ﹤0.01% |
132,600
+8,800
| +7% | +$946K |
|
|
TLMR
1214
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $14.5M | ﹤0.01% |
1,048,316
+198,316
| +23% | +$2.73M |
|
1215
Genworth Financial
GNW
$3.79B
| $14.4M | ﹤0.01% |
827,100
+58,300
| +8% | +$1.02M |
|
|
MCRS
1216
DELISTED
MICROS SYSTEMS INC
MCRS
| $14.4M | ﹤0.01% |
211,917
+17,368
| +9% | +$950K |
|
1217
Graphic Packaging
GPK
$3.46B
| $14.4M | ﹤0.01% |
1,228,713
+318,900
| +35% | +$3.42M |
|
|
PENX
1218
DELISTED
PENFORD CORP
PENX
| $14.4M | ﹤0.01% |
1,120,000
+7,700
| +0.7% | +$93.4K |
|
|
OXFD
1219
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $14.3M | ﹤0.01% |
850,800
-4,500
| -0.5% | -$81K |
|
|
NOAH
1220
Noah Holdings
NOAH
$588M
| $14.2M | ﹤0.01% |
1,005,807
+203,873
| +25% | +$2.79M |
|
1221
Enerpac Tool Group
EPAC
$1.91B
| $14.2M | ﹤0.01% |
409,300
+14,700
| +4% | +$510K |
|
1222
Sociedad Química y Minera de Chile
SQM
$20.4B
| $14.2M | ﹤0.01% |
495,812
+2,267
| +0.5% | +$67.5K |
|
1223
Nu Skin
NUS
$236M
| $14.1M | ﹤0.01% |
190,863
+12,621
| +7% | +$995K |
|
|
SNI
1224
DELISTED
Scripps Networks Interactive, Inc Common Class A
SNI
| $14.1M | ﹤0.01% |
173,590
| – | – |
|
|
HZNP
1225
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $14.1M | ﹤0.01% |
890,000
-12,400
| -1% | -$177K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.